Swami has done a fantastic job so far. He really has made a difference in trying to really make every part of the business more focused, whether it be in sales or R&D, and he’s not afraid to try to do more than one thing at the same time. It’s a big effort to have made so much progress in India in such a short period of time, but he hasn’t dropped the ball in sales in the U.S and ROW either, and all the while he has been trying to tighten the focus of their R&D spend. I guess as a new CEO, he has no baggage to carry and no qualms about setting a new direction and changing what is not working well.
It’s a real contrast to some of the leadership in other small/mid cap stocks I own
By the way, $6-$8 is quite a steal. I feel like an organisation like JnJ could really turbo charge the development of other products each of which is a company maker in its own right. Hernia, pelvic floor, etc
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)